PREGABALIN TARO 100 MG

Država: Izrael

Jezik: angleščina

Source: Ministry of Health

Aktivna sestavina:

PREGABALIN

Dostopno od:

TARO INTERNATIONAL LTD, ISRAEL

Koda artikla:

N03AX16

Farmacevtska oblika:

CAPSULES

Sestava:

PREGABALIN 100 MG

Pot uporabe:

PER OS

Tip zastaranja:

Required

Izdeluje:

SOFARIMEX – INDUSTRIA QUIMICA E FARMACEUTICA, S.A., PORTUGAL

Terapevtsko območje:

PREGABALIN

Terapevtske indikacije:

Pregabalin taro is indicated for the: • Treatment of peripheral and central neuropathic pain in adults. • Management of Fibromyalgia. • Treatment of Generalised Anxiety Disorder (GAD) in adults.

Datum dovoljenje:

2022-03-31

Navodilo za uporabo

Page 1 of 8
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS' REGULATIONS
(PREPARATIONS) -
1986
This medicine is dispensed with a doctor’s prescription only
PREGABALIN TARO 75 MG
PREGABALIN TARO 100 MG
PREGABALIN TARO 150 MG
PREGABALIN TARO 200 MG
PREGABALIN TARO 225 MG
PREGABALIN TARO 300 MG
CAPSULES
ACTIVE INGREDIENT
pregabalin 75, 100, 150, 200, 225, 300 mg
Inactive ingredients and allergens: see Section 2 under ‘Important
information about some of
this medicine’s ingredients’, and Section 6 ‘Additional
information’.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THIS MEDICINE. This
leaflet contains concise
information about this medicine. If you have further questions,
consult your doctor or
pharmacist.
This medicine has been prescribed to treat you. Do not pass it on to
others. It may harm
them, even if it seems to you that their medical condition is similar
to yours.
This medicine is not intended for treatment of children and
adolescents under 18 years of
age.
1.
WHAT IS THIS MEDICINE INTENDED FOR?
For treatment of neuropathic (neural) pain in adults, for treatment of
fibromyalgia, and for
treatment of generalized anxiety disorder (GAD) in adults.
THERAPEUTIC GROUP: A gamma-aminobutyric acid analog.
2.
BEFORE USING THIS MEDICINE
DO NOT USE THE MEDICINE IF:
•
You are sensitive (allergic) to the active ingredient or to any of the
other ingredients
in this medicine (see section 6).
SPECIAL WARNINGS ABOUT USING THIS MEDICINE
CONTACT YOUR DOCTOR BEFORE TAKING PREGABALIN TARO
•
Some patients taking Pregabalin Taro have reported allergic effects.
These effects
include swelling of the face, lips, tongue, and throat as well as
diffuse skin rash. If you
experience one or more of these effects, refer to your doctor
immediately.
•
Serious skin rashes including Stevens Johnson syndrome and toxic
epidermal
necrolysis have been reported in association with use of Pregabalin
Taro. Stop using
the medicine and refer your doctor immediately if you experience one
or more of the
symptoms related to the serio